Literature DB >> 2893589

The binding of divalent metal ions to platelet factor XIII modulates its proteolysis by trypsin and thrombin.

A Mary1, K E Achyuthan, C S Greenberg.   

Abstract

We investigated the effect of divalent metal ions on the proteolytic cleavage and activation of platelet Factor XIII by thrombin and trypsin. In the absence of metal ions (5 mM EDTA), trypsin and thrombin rapidly degraded platelet Factor XIII (80 kDa) to low-molecular-mass peptides (50-19 kDa) with simultaneous loss of transglutaminase activity. Divalent metal ions protected Factor XIII from proteolytic inactivation with an order of efficacy of Ca2+ greater than Zn2+ greater than Mg2+ greater than Mn2+. Calcium (2 mM) increased by 10- to 1000-fold the trypsin and thrombin concentrations required to degrade Factor XIII to a 19-kDa peptide. Factor XIIIa formed by thrombin in the presence of 5 mM EDTA had one-half the specific activity of Factor XIIIa formed in the presence of calcium. Factor XIII was cleaved by trypsin in the presence of 5 mM Ca2+ to a 51 +/- 3-kDa fragment that had 60% of the original Factor XIIIa activity. A similar tryptic peptide formed in the presence of 5 mM EDTA did not have transglutaminase activity. In the presence of 5 mM Mg2+, thrombin cleaved Factor XIII to a major 51 +/- 3-kDa fragment that had 60% of the Factor XIIIa activity. Mn2+ (0.1-5 mM) limited trypsin and thrombin proteolysis. The resulting digest containing a population of Factor XIII fragments (50-14 kDa) expressed 50-60% transglutaminase activity of Factor XIIIa. Factor XIII was fully activated by both trypsin and thrombin in the presence of 5 mM Zn2+, resulting in two fragments of 76 and 72 kDa. We conclude that the binding of divalent metal ions to platelet Factor XIII induces conformational changes in the protein that alter its susceptibility to proteolysis and influence the expression of transglutaminase activity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2893589     DOI: 10.1016/0003-9861(88)90110-5

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  9 in total

1.  Activation of factor XIII is accompanied by a change in oligomerization state.

Authors:  Boris A Anokhin; Vilius Stribinskis; William L Dean; Muriel C Maurer
Journal:  FEBS J       Date:  2017-10-03       Impact factor: 5.542

2.  Isolation of a fibrin-binding fragment from blood coagulation factor XIII capable of cross-linking fibrin(ogen).

Authors:  C S Greenberg; J J Enghild; A Mary; J V Dobson; K E Achyuthan
Journal:  Biochem J       Date:  1988-12-15       Impact factor: 3.857

3.  Protease digestion analysis of Escherichia coli NikR: evidence for conformational stabilization with Ni(II).

Authors:  Alistair V Dias; Deborah B Zamble
Journal:  J Biol Inorg Chem       Date:  2005-11-02       Impact factor: 3.358

4.  Role of calcium in the conformational dynamics of factor XIII activation examined by hydrogen-deuterium exchange coupled with MALDI-TOF MS.

Authors:  Ricky T Woofter; Muriel C Maurer
Journal:  Arch Biochem Biophys       Date:  2011-05-26       Impact factor: 4.013

5.  Tb(III)-ion-binding-induced conformational changes in platelet factor XIII.

Authors:  K E Achyuthan; A Mary; C S Greenberg
Journal:  Biochem J       Date:  1989-01-15       Impact factor: 3.857

6.  Consequences of terbium (III) binding on the conformation and enzymatic activity of guinea pig liver transglutaminase.

Authors:  K E Achyuthan; A Mary; R Bhaerman; C S Greenberg
Journal:  Mol Cell Biochem       Date:  1989-01-23       Impact factor: 3.396

7.  Tissue transglutaminase contributes to the pathogenesis of preeclampsia and stabilizes placental angiotensin receptor type 1 by ubiquitination-preventing isopeptide modification.

Authors:  Chen Liu; Wei Wang; Nicholas Parchim; Roxanna A Irani; Sean C Blackwell; Baha Sibai; Jianping Jin; Rodney E Kellems; Yang Xia
Journal:  Hypertension       Date:  2013-11-04       Impact factor: 10.190

8.  Non-proteolytic activation of cellular protransglutaminase (placenta macrophage factor XIII).

Authors:  J Polgár; V Hidasi; L Muszbek
Journal:  Biochem J       Date:  1990-04-15       Impact factor: 3.857

9.  Transglutaminase is a Critical Link Between Inflammation and Hypertension.

Authors:  Renna Luo; Chen Liu; Serra E Elliott; Wei Wang; Nicholas Parchim; Takayuki Iriyama; Patrick S Daugherty; Lijian Tao; Holger K Eltzschig; Sean C Blackwell; Baha M Sibai; Rodney E Kellems; Yang Xia
Journal:  J Am Heart Assoc       Date:  2016-06-30       Impact factor: 5.501

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.